The aims of COMET are the implementation and evaluation of effectiveness and cost-effectiveness as well as processes of a collaborative and stepped care model for depressive, anxiety, somatoform and/or alcohol abuse disorders within a multiprofessional network in comparison to routine care. In a cluster-randomized controlled effectiveness trial 570 patients will be recruited by 38 general practitioner practices and followed with a prospective survey at four time points. The primary outcome is the change in health-related quality of life from baseline to 6-months follow-up. Secondary outcomes include disorder-specific symptom burden, response, remission, functional quality of life, cost-effectiveness, evaluation of processes and other clinical and psychosocial variables.
Aims are a) the implementation and outcome evaluation, b) the process evaluation, and c) the analysis of the cost-effectiveness of an innovative collaborative and stepped care model for patients with depressive, anxiety, somatoform and/or alcohol abuse disorders. Its novelty is the integration of these four disorders into one model. This approach is based on a) the high comorbidity between these disorders, b) the fact that they share a common etiological and diag-nostic basis, c) that similar evidence-based treatment options exist for them (e.g., self-help and psychoeducation, psychotherapy, pharmacotherapy), and d) that health care providers need to manage them together very often. The conceptual basis follows the principles of evidence-based medicine with a specific focus on guideline implementation and the principles of patient-centered care including access, coordination and continuity of care, patient information, patient involvement and empowerment. Based on a multi-professional cooperation of health care providers across different care sectors an integrated health care network consisting of general practitioners (GPs), mental health specialists (psychiatrists, psychotherapists) and inpatient facilities will be established. Evidence-based clinical practice guidelines and pathways of care with treatment options of varying intensity form the clinical and procedural basis of the network, including low-intensity treatments and e-mental health technologies. The study is planned as a randomized controlled effectiveness trial of a consecutive sample of patients with depressive and/or anxiety and/or somatoform and/or alcohol abuse disorders drawn from primary care (GP practices) and followed with a prospective survey at four time points. The study is intended to recruit a total of 570 patients from 38 GP practices. A cluster-randomization at the level of participating GP practices divides GPs into the intervention group, where patients are treated within a multi-professional collaborative and stepped care approach (including low-intensity treatments, direct access to mental health specialists, inpatient care etc., COMET), and the control group, where patients receive standard care (treatment as usual, TAU). Data collection is carried out with questionnaires as well as telephone interviews at four time-standardized measurement points within one year (baseline, 3, 6, 12 and 24 months). Additionally, independent research assistants perform standardized diagnostic interviews (CIDI) with patients at baseline to allow an assessment of diagnostic validity. The main research hypothesis is that the COMET model is more effective than TAU. Primary outcome is the change in health-related quality of life measured by the SF-36 mental health score from baseline to 6-months follow-up. Secondary outcomes include symptom burden of depressive, generalized anxiety, panic, somatoform and alcohol abuse syndromes (PHQ-9; GAD-7; PHQ-15; PHQ panic and alcohol abuse syndrome module; SSD-12), disorder-specific response and remission, functional quality of life (EQ-5D-5L), duration of untreated illness, and other clinical and psychosocial variables (outcome evaluation, Work Package 1). Furthermore, direct and indirect costs and the incremental cost-effectiveness ratio will be assessed (economic evaluation, Work Package 2). Finally, feasibility and acceptance of the COMET model as well as of the different treatment components are assessed, including the implementation process (process evaluation, Work Package 3). To this end, semi-structured interviews will be conducted at two measurement points, supplemented by standardized surveys among involved patients and providers.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
615
Including elements: * collaborative and stepped care of patients with mental disorders * treatment in a multiprofessional network consisting of primary care physicians, psychologists, psychiatrists and inpatient facilities * initial training of participating health care providers * formalized and standardized screening procedure for early recognition of depressive, anxiety, somatoform and alcohol abuse disorders * formalized ICD-diagnostics * guideline-oriented treatment recommendations * bibliotherapy or internet-based self-help for patient with mild to moderate disorders * online referral platform * case management for patients with severe disorders * systematic and regular monitoring * regular quality circles for participating health care providers
University Medical Center Hamburg
Hamburg, Germany
change in health-related quality of life
measured with the Short Form Health Survey SF-36 mental health score
Time frame: from baseline to 6 months and 12 and 24 months after baseline
change in disorder-specific symptoms: depression
measured on the major depressive module of the Patient Health Questionnaire PHQ: PHQ-9
Time frame: from baseline to 6 months and 12 and 24 months after baseline
change in disorder-specific symptoms: panic
measured on the panic module of the Patient Health Questionnaire PHQ: PHQ-panic module
Time frame: from baseline to 6 months and 12 and 24 months after baseline
change in disorder-specific symptoms: generalized anxiety
measured on the generalized anxiety module of the Patient Health Questionnaire PHQ: GAD-7
Time frame: from baseline to 6 months and 12 months and 24 months after baseline
change in disorder-specific symptoms: somatoform syndrome PHQ
measured on the somatoform module of the Patient Health Questionnaire PHQ: PHQ-15
Time frame: from baseline to 6 months and 12 and 24 months after baseline
change in disorder-specific symptoms: somatoform syndrome SSD-12
measured on the Somatic Symptom Disorder-B SSD-12
Time frame: from baseline to 6 months and 12 and 24 months after baseline
change in disorder-specific symptoms: alcohol abuse disorder
measured on the Alcohol Use Disorders Identification Test: AUDIT
Time frame: from baseline to 6 months and 12 and 24 months after baseline
cost effectiveness: direct costs
will be assessed based on health care utilization, reduced productivity at work and work loss days measured by a modified version the Client Sociodemographic and Service Receipt Inventory (CSSRI). For the monetary valuation of resources, unit costs will be applied.
Time frame: from baseline to 6 months and 12 and 24 months after baseline
cost effectiveness: indirect costs
will be assessed based on health care utilization, reduced productivity at work and work loss days measured by a modified version the Client Sociodemographic and Service Receipt Inventory (CSSRI). Indirect costs will be calculated based on the human capital approach.
Time frame: from baseline to 6 months and 12 and 24 months after baseline
cost effectiveness: health effects
quality-adjusted life years (QALYs) will be calculated based on utilities derived from the EQ-5D-5L questionnaire
Time frame: from baseline to 6 months and 12 and 24 months after baseline
cost effectiveness: incremental cost-effectiveness
incremental cost-effectiveness ratios (ICER) will be calculated
Time frame: from baseline to 6 months and 12 and 24 months after baseline
cost effectiveness: acceptability
Cost-effectiveness acceptability curves (CEAC) will be calculated.
Time frame: from baseline to 6 months and 12 and 24 months after baseline
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.